… of this study DOAC dose was stratified as “low” (dabigatran 75 … apixaban compared with
warfarin, which our results agreed with. We found rivaroxaban to significantly increase the risk of …

… versus warfarin in patients with non-valvular atrial fibrillation (NVAF… GI bleeding, in contrast
to the dabigatran and rivaroxaban … major bleeding between patients on apixaban, dabigatran, …

… in patients with non-valvular atrial fibrillation per labels/… fewer major bleeding events compared
to warfarin. However, head-to-… the levels of dabigatran, rivaroxaban and apixaban, while …

… to be effective in patients with non valvular chronic AF, and … -dose warfarin compared with
aspirin/low-dose warfarin, with … acid, dabigatran, rivaroxaban and apixaban were associated …

… found that patients receiving the lower doses of apixaban, rivaroxaban, or dabigatran had
more … In this study, low-dose edoxaban significantly reduced the risk of stroke and SE without …

… warfarin, several AF guidelines have regarded NOACs (… patients with non-valvular AF
received at least off-label underdose or overdose of one NOAC (dabigatran, rivaroxaban, apixaban…

… hemorrhage than white populations, low-dose rivaroxaban (ie, … of rivaroxaban was >90%,
whereas that of dabigatran was 35%… warfarin in Japanese patients with atrial fibrillation—the J-…

… between warfarin and NOACs in non-valvular atrial fibrillation (NVAF) … in non-valvular atrial
fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin …

… /min, dabigatran 150 mg and apixaban were associated with … bleeding whereas both doses
of dabigatran and rivaroxaban … versus warfarin in patients with non-valvular atrial fibrillation …

… in patients with atrial fibrillation (AF) at significant stroke risk. … bleeding (including intracranial
hemorrhage) than warfarin (2… could receive rivaroxaban, apixaban, or dabigatran (the …